{"title":"嗜铬细胞瘤的相关免疫组织化学和分子病理学综述","authors":"Runjan Chetty","doi":"10.1016/j.mpdhp.2025.06.005","DOIUrl":null,"url":null,"abstract":"<div><div><span><span><span>While morphologically distinct, immunohistochemistry for </span>tyrosine<span> hydroxlase is a sensitive and specific immunohistochemical marker for phaeochrmocytomas. Other useful negative routine markers include cytokeratin, melanocytic markers, TTF-1 and PAX-8. Markers that indicate specific </span></span>genetic<span><span> syndromic cases include succinate dehydrogenase<span> A and B, myc-associated factor X<span>, fumarate hydratase<span><span> and 2-Succinocysteine. Prognostic markers include: Ki-67, p53, heat shock protein-90, TERT and N-cadherin. Hereditary </span>phaeochromocytomas with </span></span></span></span>germline<span><span> gene mutations are grouped into several pathways: pseudohypoxia, </span>kinase signalling<span>, wnt signalling, mitochondrial pathways and miscellaneous. Key genes in these pathways include: </span></span></span></span><span><em>HRAS</em></span>, <em>HIF2A</em>, <em>RET</em> and <span><em>NF1</em></span>. Prognostic genes are <span><span>SDHB</span></span>, <span><span>ATRX</span></span> and <span><em>TERT</em></span><span>. Understanding the pathological, immunohistochemical and genetic landscape of phaeochromocytomas enables a multimodal approach to determining behaviour and targeted therapy.</span></div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"31 9","pages":"Pages 521-523"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An overview of pertinent immunohistochemistry and molecular pathology of phaeochromocytoma\",\"authors\":\"Runjan Chetty\",\"doi\":\"10.1016/j.mpdhp.2025.06.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><span><span><span>While morphologically distinct, immunohistochemistry for </span>tyrosine<span> hydroxlase is a sensitive and specific immunohistochemical marker for phaeochrmocytomas. Other useful negative routine markers include cytokeratin, melanocytic markers, TTF-1 and PAX-8. Markers that indicate specific </span></span>genetic<span><span> syndromic cases include succinate dehydrogenase<span> A and B, myc-associated factor X<span>, fumarate hydratase<span><span> and 2-Succinocysteine. Prognostic markers include: Ki-67, p53, heat shock protein-90, TERT and N-cadherin. Hereditary </span>phaeochromocytomas with </span></span></span></span>germline<span><span> gene mutations are grouped into several pathways: pseudohypoxia, </span>kinase signalling<span>, wnt signalling, mitochondrial pathways and miscellaneous. Key genes in these pathways include: </span></span></span></span><span><em>HRAS</em></span>, <em>HIF2A</em>, <em>RET</em> and <span><em>NF1</em></span>. Prognostic genes are <span><span>SDHB</span></span>, <span><span>ATRX</span></span> and <span><em>TERT</em></span><span>. Understanding the pathological, immunohistochemical and genetic landscape of phaeochromocytomas enables a multimodal approach to determining behaviour and targeted therapy.</span></div></div>\",\"PeriodicalId\":39961,\"journal\":{\"name\":\"Diagnostic Histopathology\",\"volume\":\"31 9\",\"pages\":\"Pages 521-523\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diagnostic Histopathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756231725001094\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Histopathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756231725001094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
An overview of pertinent immunohistochemistry and molecular pathology of phaeochromocytoma
While morphologically distinct, immunohistochemistry for tyrosine hydroxlase is a sensitive and specific immunohistochemical marker for phaeochrmocytomas. Other useful negative routine markers include cytokeratin, melanocytic markers, TTF-1 and PAX-8. Markers that indicate specific genetic syndromic cases include succinate dehydrogenase A and B, myc-associated factor X, fumarate hydratase and 2-Succinocysteine. Prognostic markers include: Ki-67, p53, heat shock protein-90, TERT and N-cadherin. Hereditary phaeochromocytomas with germline gene mutations are grouped into several pathways: pseudohypoxia, kinase signalling, wnt signalling, mitochondrial pathways and miscellaneous. Key genes in these pathways include: HRAS, HIF2A, RET and NF1. Prognostic genes are SDHB, ATRX and TERT. Understanding the pathological, immunohistochemical and genetic landscape of phaeochromocytomas enables a multimodal approach to determining behaviour and targeted therapy.
期刊介绍:
This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances. Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and advances in technology. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. An additional feature is the short section devoted to hypotheses; these have been refereed. There is also a correspondence section.